89bio Company

89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.
Technology: Other
Industry: Geroscience
Headquarters: United States
Founded Date: 2018
Investors Number: 4
Total Funding: £27M
Estimated Revenue: Less than $1M
Last Funding Type: Series A

Visit Website
info@89bio.com
Register and Claim Ownership